PHESGO also contains hyaluronidase, which makes the tissue under the skin more absorbent temporarily so that it’s able to receive the medication.
PERJETA and Herceptin work together to block HER2 receptors. Each treatment is designed to block a different part of the HER2 receptor to stop cells from growing and dividing into new cancer cells. Normal cells also have some HER2 receptors, so targeted therapies, like PERJETA, Herceptin or PHESGO, may also affect them.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.